Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 2 | 2025 | 287 | 0.780 |
Why?
|
| Skin Ulcer | 1 | 2021 | 33 | 0.750 |
Why?
|
| Intestinal Fistula | 1 | 2021 | 28 | 0.750 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 218 | 0.740 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 553 | 0.660 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 238 | 0.610 |
Why?
|
| Biological Products | 1 | 2021 | 137 | 0.610 |
Why?
|
| Virtual Reality | 1 | 2018 | 32 | 0.580 |
Why?
|
| Preceptorship | 1 | 2018 | 33 | 0.580 |
Why?
|
| Manikins | 1 | 2018 | 138 | 0.550 |
Why?
|
| Teaching | 1 | 2018 | 200 | 0.530 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 244 | 0.530 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 285 | 0.520 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 324 | 0.510 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 74 | 0.490 |
Why?
|
| Cost of Illness | 1 | 2017 | 275 | 0.470 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 253 | 0.460 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 677 | 0.430 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 933 | 0.390 |
Why?
|
| Caregivers | 1 | 2017 | 585 | 0.370 |
Why?
|
| Colonoscopy | 3 | 2015 | 250 | 0.280 |
Why?
|
| Gastrointestinal Agents | 1 | 2025 | 67 | 0.230 |
Why?
|
| Colonic Polyps | 2 | 2015 | 82 | 0.210 |
Why?
|
| Adenoma | 2 | 2015 | 142 | 0.200 |
Why?
|
| Colon | 2 | 2024 | 381 | 0.200 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 288 | 0.180 |
Why?
|
| Biological Factors | 1 | 2021 | 27 | 0.180 |
Why?
|
| Severity of Illness Index | 3 | 2025 | 3065 | 0.170 |
Why?
|
| Infliximab | 1 | 2021 | 68 | 0.170 |
Why?
|
| Proteomics | 1 | 2024 | 589 | 0.160 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 86 | 0.160 |
Why?
|
| Barrett Esophagus | 1 | 2024 | 355 | 0.160 |
Why?
|
| Drug Monitoring | 1 | 2021 | 180 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 393 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1198 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 1069 | 0.150 |
Why?
|
| Humans | 15 | 2025 | 133455 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 707 | 0.140 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 649 | 0.140 |
Why?
|
| Nadolol | 1 | 2016 | 29 | 0.130 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 84 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 822 | 0.130 |
Why?
|
| Propranolol | 1 | 2016 | 129 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 99 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1478 | 0.120 |
Why?
|
| Primary Prevention | 1 | 2016 | 179 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 261 | 0.110 |
Why?
|
| Comorbidity | 2 | 2016 | 1606 | 0.110 |
Why?
|
| Proctoscopy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 431 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 405 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 344 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 601 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 29 | 0.100 |
Why?
|
| Adenomatous Polyps | 1 | 2013 | 13 | 0.100 |
Why?
|
| Age Factors | 2 | 2016 | 2978 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1731 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 83 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 471 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 705 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 373 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 600 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2025 | 12987 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2017 | 552 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 995 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 271 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1405 | 0.080 |
Why?
|
| Middle Aged | 5 | 2025 | 29299 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2016 | 5176 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2016 | 3682 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 2156 | 0.060 |
Why?
|
| Remission Induction | 1 | 2025 | 308 | 0.060 |
Why?
|
| Optical Fibers | 1 | 2024 | 19 | 0.060 |
Why?
|
| United States | 2 | 2016 | 11645 | 0.050 |
Why?
|
| Adult | 3 | 2025 | 31881 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2025 | 17413 | 0.050 |
Why?
|
| Risk Factors | 1 | 2016 | 11054 | 0.050 |
Why?
|
| Male | 5 | 2025 | 65713 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 621 | 0.040 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 26 | 0.040 |
Why?
|
| Aged | 2 | 2016 | 21664 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 38 | 0.040 |
Why?
|
| Biopsy | 1 | 2024 | 1301 | 0.040 |
Why?
|
| Female | 4 | 2025 | 71472 | 0.040 |
Why?
|
| Microbiota | 1 | 2024 | 444 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 929 | 0.040 |
Why?
|
| Health Status | 1 | 2016 | 412 | 0.030 |
Why?
|
| Proctoscopes | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 502 | 0.030 |
Why?
|
| Colonoscopes | 1 | 2013 | 10 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 201 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 387 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 46 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 75 | 0.030 |
Why?
|
| Microscopy | 1 | 2013 | 123 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 203 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1487 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 113 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2013 | 169 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1381 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 314 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 337 | 0.020 |
Why?
|
| Video Recording | 1 | 2013 | 202 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 413 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2199 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1139 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9881 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3632 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 633 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 880 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 932 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1963 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 814 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2302 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1389 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 6649 | 0.010 |
Why?
|
| Heart Failure | 1 | 2016 | 2393 | 0.010 |
Why?
|